A photo of Cuixia Tian.

Cuixia Tian, MD

  • Director, MDA Clinic and PPMD Certified DMD Clinic, Division of Neurology
  • Neuromuscular Disease Specialist, Division of Neurology
  • Associate Professor, UC Department of Pediatrics
appointment iconMake An Appointment
MyChart Icon
Existing PatientsMyChart Scheduling
AppointmentsCall Us to ScheduleAppointments1-513-636-3200
My team and I are focused on families' concerns and work together to provide the best care possible to our patients.
Cuixia Tian, MD

About

Biography

I'm a board-certified child neurologist who specializes in neuromuscular diseases. I am co-director of the multidisciplinary comprehensive neuromuscular care program and serve as the program's neurology lead. I'm also the clinical director of the Parent Project Muscular Dystrophy (PPMD) Certified Duchenne Muscular Dystrophy (DMD) Clinic and clinical director of the Muscular Dystrophy Association (MDA) Care Center.

My mom was a devoted elementary teacher, loved by many of her students. Her love for children inspired me, and I became a pediatrician. I am honored to be recognized by Cincinnati Magazine’s Top Doctors in Pediatric Neurology (2023).

I'm passionate about caring for children and young adults with chronic neuromuscular disease. I love meeting families and listening to parents advocating for their children. My team and I are focused on families' concerns and work together to provide the best care possible to our patients.

As a clinical researcher, I actively lead and collaborate on multiple clinical trials and research studies in pediatric neuromuscular diseases to develop advanced therapies and improve clinical care for our patients.

When I'm not at work, I love music and the arts. I also enjoy gardening and playing tennis.

MD: Medical Center of Fudan University, Shanghai, China, 1993.

Residency: Cincinnati Children’s Hospital Medical Center.

Myology Institute Clinical Myology Training; Paris, France, 2014.

Wellstone Myology Training; Ohio State University, Columbus, OH, 2013.

World Muscle Society Satellite Training; Asilomar, California, 2013.

Services and Specialties

Additional Languages

Chinese

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Cardiac Histopathology in Duchenne Muscular Dystrophy Demonstrates Diffuse Fibrofatty Replacement of the Myocardium. Breaux, A; Lang, SM; Wittekind, S; Ryan, TD; Taylor, M; Greiner, E; Tian, C; Kasten, J; Sawnani, H; Villa, CR. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2024; 13:e033862.

The impact of genotype on age at loss of ambulation in individuals with Duchenne muscular dystrophy treated with corticosteroids: A single-center study of 555 patients. Zygmunt, A; Wong, B; Moon, D; Horn, P; Rathbun, R; Lambert, J; Bange, J; Rybalsky, I; Reebals, L; Tian, C. Muscle and Nerve. 2024; 70:1053-1061.

330P Trends in creatine kinase levels and 10-meter walk-run velocity in pediatric Becker muscular dystrophy treated with glucocorticoid steroids. Zygmunt, A; Vilaisaktipakorn, P; Sharaf, T; Shiuan, Y; Horn, P; Bange, J; Reebals, L; Rybalsky, I; Tian, C. Neuromuscular Disorders. 2024; 43:104441.661.

328P Navigating dystrophinopathies: dual diagnosis and their implications. Bhimarao Nagaraj, C; Reebals, L; Zygmunt, A; Tian, C. Neuromuscular Disorders. 2024; 43:104441.659.

329P Siblings with Duchenne muscular dystrophy: a chart review to explore associations between age of diagnosis and clinical disease outcomes. Bhimarao Nagaraj, C; Brahmamdam, V; Pilipenko, V; Armstrong, N; Zygmunt, A; Rybalsky, I; Reebals, L; Tian, C. Neuromuscular Disorders. 2024; 43:104441.660.

324P A longitudinal study of creatine kinase, creatinine levels, and appendicular lean mass index in pediatric Becker muscular dystrophy. Horn, P; Zygmunt, A; Vilaisaktipakorn, P; Sharaf, T; Shiuan, Y; Rybalsky, I; Reebals, L; Bange, J; Tian, C. Neuromuscular Disorders. 2024; 43:104441.655.

326P Acute adverse events after Zoledronic acid infusion are uncommon in patients with Duchenne muscular dystrophy previously treated with oral bisphosphonates. Vilaisaktipakorn, P; Nasomyont, N; Hornung, L; Tian, C; Wasserman, H; Rutter, M. Neuromuscular Disorders. 2024; 43:104441.657.

327P Correlation of biomarkers and timed function tests in pediatric Becker muscular dystrophy. Vilaisaktipakorn, P; Zygmunt, A; Sharaf, T; Shiuan, Y; Horn, P; Bange, J; Reebals, L; Rybalsky, I; Tian, C. Neuromuscular Disorders. 2024; 43:104441.658.

Compound Heterozygous Variants of GOSR2 Associated With Congenital Muscular Dystrophy and Progressive Myoclonus Epilepsy: A Case Report. Arroyo, MS; Fuller, C; Schorry, EK; Ulm, E; Tian, C. Neurology: Genetics. 2024; 10:e200177.

Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations. Schroth, M; Deans, J; Arya, K; Castro, D; De Vivo, DC; Gibbons, MA; Ionita, C; Kuntz, NL; Lakhotia, A; Neil Knierbein, E; Servais, L; Tian, C; Waldrop, MA; Vázquez-Costa, JF. Neurology: Clinical Practice. 2024; 14:e200310.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating
Give Today

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026

© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.

U.S. News & World Report Honor Roll Badge for Top Children's Hospital.Best Places to Work.America's Best Large Employers